Q3 2025 Earnings Call Transcript April 2, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $0.03, ...
Subgroup analyses identified that OAC discontinuation was associated with higher thromboembolic risk in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback